|
Neoplasia
Citations 381-390 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition
- Wee J. Chng, Esteban Braggio, George Mulligan, Barbara Bryant, Ellen Remstein, Riccardo Valdez, Ahmet Dogan, and Rafael Fonseca
Blood 2008; 111: 1603-1609.
[Abstract]
[Full text]
[PDF]
Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia
- Jun Yang, P. K. Epling-Burnette, Jeffrey S. Painter, JianXiang Zou, Fanqi Bai, Sheng Wei, and Thomas P. Loughran, Jr
Blood 2008; 111: 1610-1616.
[Abstract]
[Full text]
[PDF]
Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference
- Eva Ortega-Paino, Johan Fransson, Sara Ek, and Carl A. K. Borrebaeck
Blood 2008; 111: 1617-1624.
[Abstract]
[Full text]
[PDF]
Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis
- Gabrielle S. Sellick, Rachel Wade, Susan Richards, David G. Oscier, Daniel Catovsky, and Richard S. Houlston
Blood 2008; 111: 1625-1633.
[Abstract]
[Full text]
[PDF]
Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RAR
- Sake van Wageningen, Marleen C. Breems-de Ridder, Jeannet Nigten, Gorica Nikoloski, Claudia A. J. Erpelinck-Verschueren, Bob Löwenberg, Theo de Witte, Daniel G. Tenen, Bert A. van der Reijden, and Joop H. Jansen
Blood 2008; 111: 1634-1643.
[Abstract]
[Full text]
[PDF]
Protein kinase C–associated kinase is required for NF- B signaling and survival in diffuse large B-cell lymphoma cells
- Sang-Woo Kim, David W. Oleksyn, Randall M. Rossi, Craig T. Jordan, Ignacio Sanz, Luojing Chen, and Jiyong Zhao
Blood 2008; 111: 1644-1653.
[Abstract]
[Full text]
[PDF]
Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma
- Dharminder Chauhan, Ajita Singh, Mohan Brahmandam, Klaus Podar, Teru Hideshima, Paul Richardson, Nikhil Munshi, Michael A. Palladino, and Kenneth C. Anderson
Blood 2008; 111: 1654-1664.
[Abstract]
[Full text]
[PDF]
Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways
- Antonio Ruiz-Vela, Mohit Aggarwal, Paloma de la Cueva, Cezary Treda, Beatriz Herreros, Daniel Martín-Pérez, Orlando Dominguez, and Miguel A. Piris
Blood 2008; 111: 1665-1676.
[Abstract]
[Full text]
[PDF]
Pim-1 and Pim-2 kinases are required for efficient pre–B-cell transformation by v-Abl oncogene
- Ji-Long Chen, Andre Limnander, and Paul B. Rothman
Blood 2008; 111: 1677-1685.
[Abstract]
[Full text]
[PDF]
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
- Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Robert Kralovics, Laura Cremonesi, Radek Skoda, and Mario Cazzola
Blood 2008; 111: 1686-1689.
[Abstract]
[Full text]
[PDF]
|
|
